Bellevue Group AG 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-05 5:42 pm Sale | 2025-11-19 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Bellevue Group AG | 0 0.000% | -3,515,150 (Position Closed) | Filing |
| 2025-07-07 7:32 pm Purchase | 2025-06-01 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Bellevue Group AG | 3,515,150 6.100% | 3,515,150 (New Position) | Filing |